A recent study investigated whether anti-beta2-glycoprotein I (anti-beta2-glycoprotein I antibodies) and aCL antibodies are correlated with macrovascular disease, including digital loss in SSc patients. The gene discussed is ACLY; the disease is systemic sclerosis.